van Els CACM - Search Results

1

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.

Stalman EW, Wieske L, van Dam KPJ, Kummer LY, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, Van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng OYK, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, Van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, Rispens T, van Ham SM, Kuijpers TW, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Stalman EW, et al. Among authors: van der pol wl, van der kooi aj, van ham sm, van paassen p, van els cacm, van dam kpj, van kempen zle, van doorn pa, van der woude d, van ouwerkerk l. Ann Rheum Dis. 2022 Dec;81(12):1757-1766. doi: 10.1136/ard-2022-222904. Epub 2022 Sep 5. Ann Rheum Dis. 2022. PMID: 36357161

2

Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube.

Botafogo V, Pérez-Andres M, Jara-Acevedo M, Bárcena P, Grigore G, Hernández-Delgado A, Damasceno D, Comans S, Blanco E, Romero A, Arriba-Méndez S, Gastaca-Abasolo I, Pedreira CE, van Gaans-van den Brink JAM, Corbiere V, Mascart F, van Els CACM, Barkoff AM, Mayado A, van Dongen JJM, Almeida J, Orfao A. Botafogo V, et al. Among authors: van gaans van den brink jam, van els cacm, van dongen jjm. Front Immunol. 2020 Feb 27;11:166. doi: 10.3389/fimmu.2020.00166. eCollection 2020. Front Immunol. 2020. PMID: 32174910 Free PMC article.

3

A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.

Herberts CA, Stittelaar KJ, van der Heeft E, van Gaans-van den Brink J, Poelen MCM, Roholl PJM, van Alphen LJW, Melief CJM, de Jong APJM, van Els CACM. Herberts CA, et al. Among authors: van der heeft e, van alphen ljw, van els cacm, van gaans van den brink j. J Gen Virol. 2001 Sep;82(Pt 9):2131-2142. doi: 10.1099/0022-1317-82-9-2131. J Gen Virol. 2001. PMID: 11514722

4

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens.

Schipper RF, van Els CA, D'Amaro J, Oudshoorn M. Schipper RF, et al. Hum Immunol. 1996 Dec;51(2):95-8. doi: 10.1016/s0198-8859(96)00138-3. Hum Immunol. 1996. PMID: 8960911

5

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker M, Bontrop RE, Osterhaus A. Heeney JL, et al. J Exp Med. 1994 Aug 1;180(2):769-74. doi: 10.1084/jem.180.2.769. J Exp Med. 1994. PMID: 8046353 Free PMC article.

6

Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance.

van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ, van Rood JJ, Goulmy E. van Els CA, et al. Immunogenetics. 1992;35(3):161-5. doi: 10.1007/BF00185109. Immunogenetics. 1992. PMID: 1537607 Free article.

7

A new sensitive assay for measurement of cell-mediated cytotoxicity to intact layers of cultured human keratinocytes.

De Bueger MM, Van Els CA, Kempenaar J, Ponec M, Goulmy E. De Bueger MM, et al. J Immunol Methods. 1990 Feb 20;127(1):117-22. doi: 10.1016/0022-1759(90)90347-x. J Immunol Methods. 1990. PMID: 2108219

8

Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells.

van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E. van Els CA, et al. Transplantation. 1990 Jul;50(1):62-6. doi: 10.1097/00007890-199007000-00011. Transplantation. 1990. PMID: 2368152

9

Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells.

van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E. van Els CA, et al. Transplantation. 1990 Jul;50(1):67-71. doi: 10.1097/00007890-199007000-00012. Transplantation. 1990. PMID: 2142346

10

The role of minor histocompatibility antigens in GVHD and rejection: a mini-review.

Goulmy E, Voogt P, van Els C, de Bueger M, van Rood J. Goulmy E, et al. Bone Marrow Transplant. 1991;7 Suppl 1:49-51. Bone Marrow Transplant. 1991. PMID: 2043886 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page